STEPHEN GOTTSCHALK, MD
Medical Practice at Fannin St, Houston, TX
License number
Texas L2286
Category
Osteopathic Medicine
Type
Hematology & Oncology
License number
Texas L2286
Category
Medical Practice
Type
Pediatrics
License number
Texas L2286
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
6701 Fannin St, Houston, TX 77030
Phone
(832) 822-4240
(832) 825-4247 (Fax)
(832) 825-4247 (Fax)
Personal information
See more information about STEPHEN GOTTSCHALK at radaris.comName
Address
Phone
1908 Canterbury St, Houston, TX 77030
1908 Canterbury St, Houston, TX 77030
2318 Blue Bonnet Blvd, Houston, TX 77030
4108 Pirates Bch, Galveston, TX 77554
4110 Mount Vernon St, Houston, TX 77006
Organization information
See more information about STEPHEN GOTTSCHALK at bizstanding.comStephen Gottschalk MD
6701 Fannin St, Houston, TX 77030
Industry:
Oncology, Pediatric Oncologist, Pediatrician, ...
Phone:
(832) 822-4240 (Phone)
Stephen Max G Gottschalk
Professional information
See more information about STEPHEN GOTTSCHALK at trustoria.com
Chimeric Cd27 Receptors For Redirecting T Cells To Cd70-Positive Malignancies
Chimeric Cd27 Receptors For Redirecting T Cells To Cd70-Positive Malignancies
US Patent:
2013032, Dec 5, 2013
Filed:
Oct 27, 2011
Appl. No.:
13/881772
Inventors:
Stephen M.G. Gottschalk - Houston TX, US
Donald R. Shaffer - Houston TX, US
David M. Spencer - Houston TX, US
Donald R. Shaffer - Houston TX, US
David M. Spencer - Houston TX, US
International Classification:
A61K 45/06, A61K 35/14
US Classification:
424 9321, 530350, 435375, 536 235
Abstract:
The present invention concerns methods and compositions related to T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies. In aspects of the invention, T cells that are CD70-specific are employed. In particular aspects, there are T cells expressing a novel molecule that comprises the full-length CD70 receptor (CD27) fused to the zeta signaling domain of the T-cell receptor complex. Such T cells recognized CD70-positive tumor cells and have cytolytic activity against CD70-positive cancer cells.
Stephen M Gottschalk, Houston TX
Stephen M Gottschalk, Houston TX
Specialties:
Pediatric Hematologist / Oncologist
Address:
6701 Fannin St, Houston, TX 77030
1102 Bates Ave, Houston, TX 77030
1102 Bates Ave, Houston, TX 77030
Education:
Medical University of Gottingen, Faculty of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Associate Professor At Baylor College Of Medicine
Associate Professor At Baylor College Of Medicine
Position:
Associate Professor at Baylor College of Medicine
Location:
Houston, Texas Area
Industry:
Medical Practice
Work:
Baylor College of Medicine
since Jul 2001
-
Associate Professor
Stephen Max G Gottschalk, Houston TX
Stephen Max G Gottschalk, Houston TX
Specialties:
Pediatrics, Pediatric Hematology-Oncology, Hematology & Oncology, Medical Oncology
Work:
Texas Childrens Cancer Center And Hematology Service Clinica
6701 Fannin St, Houston, TX 77030 Baylor College of Medicine
6620 Main St, Houston, TX 77030 Baylor College of Medicine
1102 Bates Ave, Houston, TX 77030
6701 Fannin St, Houston, TX 77030 Baylor College of Medicine
6620 Main St, Houston, TX 77030 Baylor College of Medicine
1102 Bates Ave, Houston, TX 77030
Education:
Georg-August-Universitaet Gottingen (1992)
Dr. Stephen Gottschalk, Houston TX - MD (Doctor of Medicine)
Dr. Stephen Gottschalk, Houston TX - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
1102 Banks St SUITE 1770, Houston 77006
Texas Childrens Hosp Cancr Ctr
6701 Fannin St SUITE 14, Houston 77030
(832) 822-4302 (Phone)
CHILDREN'S HOSPITAL
6701 Fannin St, Houston 77030
(832) 824-1000 (Phone), (832) 825-3127 (Fax)
Texas Childrens Hosp Cancr Ctr
6701 Fannin St SUITE 14, Houston 77030
(832) 822-4302 (Phone)
CHILDREN'S HOSPITAL
6701 Fannin St, Houston 77030
(832) 824-1000 (Phone), (832) 825-3127 (Fax)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2002, Pediatrics, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Georg August Univ
Baylor College Of Med
Georg August Univ
Baylor College Of Med
Immunotherapy Of Cancer Using Genetically Engineered Gd2-Specific T Cells
Immunotherapy Of Cancer Using Genetically Engineered Gd2-Specific T Cells
US Patent:
2014000, Jan 2, 2014
Filed:
Sep 8, 2011
Appl. No.:
13/820931
Inventors:
Malcolm Brenner - Houston TX, US
Gianpietro Dotti - Houston TX, US
Nabil Ahmed - Houston TX, US
Claudia Rossig - Heidelberg, DE
Stephen M.G. Gottschalk - Houston TX, US
Zakaria Grada - Houston TX, US
Gianpietro Dotti - Houston TX, US
Nabil Ahmed - Houston TX, US
Claudia Rossig - Heidelberg, DE
Stephen M.G. Gottschalk - Houston TX, US
Zakaria Grada - Houston TX, US
International Classification:
C12N 5/0783, C07K 16/18
US Classification:
4241781, 424 9321, 435375
Abstract:
The present invention concerns immunotherapy for cancers having cells that comprise the ganglioside GD2 antigen. In specific embodiment, T cells having a chimeric receptor that targets GD2 is employed. In particular cases, the chimeric receptor comprises antibody, cytoplasmic signaling domain from the T cell receptor, and/or costimulatory molecule(s).